Real-world effectiveness of recombinant herpes Zoster vaccine: a retrospective, cohort study in Japan

Abstract Background In Japan, a two-dose, recombinant herpes zoster vaccine (RZV) has been available since 2020, but vaccination coverage is low because vaccination is voluntary. This study investigated the real-world effectiveness of the RZV for preventing herpes zoster (HZ) by using clinical datab...

Full description

Saved in:
Bibliographic Details
Main Authors: Satoko Ohfuji, Nozomu Toyama, Kyoko Kondo, Hisao Muto, Wakaba Fukushima
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-025-11369-5
Tags: Add Tag
No Tags, Be the first to tag this record!